Jalra-OD 100mg Tablet SR
Marketer
USV Ltd
Salt Composition
Vildagliptin (100mg)
Overview Jalra-OD 100mg Tablet SR
Canagliflozin 100mg extended-release tablets are indicated for the management of type 2 diabetes. This medication complements a balanced diet and regular physical activity to regulate blood glucose, thereby reducing the risk of severe diabetic complications such as nephropathy and vision impairment. Prescribing typically occurs when dietary and exercise modifications, or other treatments, prove inadequate in achieving glycemic control. It can be administered alone or in conjunction with other antidiabetic agents and may be taken with or without food. Dosage adjustments are based on individual patient needs and blood sugar monitoring. Adherence to the prescribed regimen is crucial for optimal therapeutic efficacy. Consistent daily dosing at the same time is recommended. Discontinuation should only occur under medical supervision. Continued adherence to the physician-recommended diet and exercise plan is essential for effective diabetes management. Lifestyle factors significantly influence diabetes control. Commonly reported adverse reactions include hypoglycemia, trembling, cephalalgia, vertigo, lassitude, and nausea. Recognizing hypoglycemic symptoms (e.g., lightheadedness, diaphoresis, vertigo, syncope, xerostomia) and implementing appropriate countermeasures (such as consuming glucose tablets) is vital. Consult your doctor if side effects persist or cause concern. Prior to commencing treatment, inform your physician of any history of renal or cardiac disease, or pancreatic disorders. Pregnant or lactating women should seek medical advice before using this medication. Potential drug interactions necessitate full disclosure of all other medications being used. Alcohol consumption should be moderated due to its potential to exacerbate hypoglycemia. Regular monitoring of renal function and blood glucose levels may be necessary to assess treatment effectiveness.
Uses of Jalra-OD 100mg Tablet SR
Managing type 2 diabetes
Major Benefits of Jalra-OD 100mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Jalra-OD 100mg Sustained-Release Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Jalra-OD 100mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Tremors
- Headache
- Dizziness
- Fatigue
- Nausea
How to use Jalra-OD 100mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Jalra-OD 100mg Sustained-Release tablets can be consumed with or without food, though consistent timing is recommended.
How Jalra-OD 100mg Tablet SR works:
Omnidip 100mg Extended-Release Tablets are used to manage diabetes. Their mechanism involves stimulating pancreatic insulin secretion while concurrently suppressing hyperglycemic hormones. This action leads to lower blood glucose readings both before and after meals.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while taking a 100mg sustained-release Jalra-OD tablet is undetermined. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Jalra-OD 100mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks before prescribing this medication. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Sustained-release Jalra-OD 100mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Jalra-OD 100mg sustained-release tablets may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, the extended-release Jalra-OD 100mg tablet is generally considered safe. A dosage change isn't typically necessary. Nevertheless, patients experiencing moderate to severe kidney impairment might need an adjusted dose. Physician consultation is advised.
LiverUNSAFE
Extended-release Jalra 100mg tablets are likely contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is advised.
What if you forget to take Jalra-OD 100mg Tablet SR :
Should you forget a dose of Jalra-OD 100mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Jalra-OD 100mg Tablet SR
| Label | Value |
|---|---|
| Chemical Category | Pyrrolidinecarbonitrile derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Active Class | Dipeptidyl peptidase-4 inhibitors |




